141 related articles for article (PubMed ID: 29927618)
1. Sertoli Cells Engineered to Express Insulin to Lower Blood Glucose in Diabetic Mice.
Kaur G; Thompson LA; Babcock RL; Mueller K; Dufour JM
DNA Cell Biol; 2018 Aug; 37(8):680-690. PubMed ID: 29927618
[TBL] [Abstract][Full Text] [Related]
2. Sustained expression of insulin by a genetically engineered sertoli cell line after allotransplantation in diabetic BALB/c mice.
Kaur G; Thompson LA; Pasham M; Tessanne K; Long CR; Dufour JM
Biol Reprod; 2014 May; 90(5):109. PubMed ID: 24695630
[TBL] [Abstract][Full Text] [Related]
3. Delivery of a therapeutic protein by immune-privileged Sertoli cells.
Halley K; Dyson EL; Kaur G; Mital P; Uong PM; Dass B; Crowell SN; Dufour JM
Cell Transplant; 2010; 19(12):1645-57. PubMed ID: 20719072
[TBL] [Abstract][Full Text] [Related]
4. Adult rat liver cells transdifferentiated with lentiviral IPF1 vectors reverse diabetes in mice: an ex vivo gene therapy approach.
Fodor A; Harel C; Fodor L; Armoni M; Salmon P; Trono D; Karnieli E
Diabetologia; 2007 Jan; 50(1):121-30. PubMed ID: 17131142
[TBL] [Abstract][Full Text] [Related]
5. Sertoli cell line lacks the immunoprotective properties associated with primary Sertoli cells.
Dufour JM; Dass B; Halley KR; Korbutt GS; Dixon DE; Rajotte RV
Cell Transplant; 2008; 17(5):525-34. PubMed ID: 18714671
[TBL] [Abstract][Full Text] [Related]
6. Genetically engineered Sertoli cells are able to survive allogeneic transplantation.
Dufour JM; Hemendinger R; Halberstadt CR; Gores P; Emerich DF; Korbutt GS; Rajotte RV
Gene Ther; 2004 Apr; 11(8):694-700. PubMed ID: 14724669
[TBL] [Abstract][Full Text] [Related]
7. Immunoregulatory Sertoli Cell Allografts Engineered to Express Human Insulin Survive Humoral-Mediated Rejection.
Washburn RL; Hibler T; Kaur G; Sabu-Kurian A; Landefeld A; Dufour JM
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555540
[TBL] [Abstract][Full Text] [Related]
8. Somatic gene therapy for diabetes with an immunological safety system for complete removal of transplanted cells.
Kawakami Y; Yamaoka T; Hirochika R; Yamashita K; Itakura M; Nakauchi H
Diabetes; 1992 Aug; 41(8):956-61. PubMed ID: 1628770
[TBL] [Abstract][Full Text] [Related]
9. Constant delivery of proinsulin by encapsulation of transfected cells.
Taniguchi H; Fukao K; Nakauchi H
J Surg Res; 1997 Jun; 70(1):41-5. PubMed ID: 9228925
[TBL] [Abstract][Full Text] [Related]
10. Comparison of successful and unsuccessful islet/Sertoli cell cotransplant grafts in streptozotocin-induced diabetic mice.
Dufour JM; Lord SJ; Kin T; Rayat GR; Dixon DE; Bleackley RC; Korbutt GS; Rajotte RV
Cell Transplant; 2008; 16(10):1029-38. PubMed ID: 18351019
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy for streptozotocin-induced diabetic mice by electroporational transfer of naked human insulin precursor DNA into skeletal muscle in vivo.
Yin D; Tang JG
FEBS Lett; 2001 Apr; 495(1-2):16-20. PubMed ID: 11322940
[TBL] [Abstract][Full Text] [Related]
12. Glucose-dependent insulin release from genetically engineered K cells.
Cheung AT; Dayanandan B; Lewis JT; Korbutt GS; Rajotte RV; Bryer-Ash M; Boylan MO; Wolfe MM; Kieffer TJ
Science; 2000 Dec; 290(5498):1959-62. PubMed ID: 11110661
[TBL] [Abstract][Full Text] [Related]
13. Reversal of diabetes through gene therapy of diabetic rats by hepatic insulin expression via lentiviral transduction.
Elsner M; Terbish T; Jörns A; Naujok O; Wedekind D; Hedrich HJ; Lenzen S
Mol Ther; 2012 May; 20(5):918-26. PubMed ID: 22354377
[TBL] [Abstract][Full Text] [Related]
14. Failure to achieve normal metabolic response in non-obese diabetic mice and streptozotocin-induced diabetic mice after transplantation of primary murine hepatocytes electroporated with the human proinsulin gene (p3MTChins).
Lee RH; Roll G; Nguyen V; Willenbring H; Tang Q; Kang SM; Stock PG
Transplant Proc; 2014; 46(6):2002-6. PubMed ID: 25131094
[TBL] [Abstract][Full Text] [Related]
15. Nondividing, postpubertal rat sertoli cells resumed proliferation after transplantation.
Mital P; Kaur G; Bowlin B; Paniagua NJ; Korbutt GS; Dufour JM
Biol Reprod; 2014 Jan; 90(1):13. PubMed ID: 24285718
[TBL] [Abstract][Full Text] [Related]
16. Long-term correction of diabetes in rats after lentiviral hepatic insulin gene therapy.
Ren B; O'Brien BA; Swan MA; Koina ME; Nassif N; Wei MQ; Simpson AM
Diabetologia; 2007 Sep; 50(9):1910-1920. PubMed ID: 17598085
[TBL] [Abstract][Full Text] [Related]
17. Lentivirus Mediated Pancreatic Beta-Cell-Specific Insulin Gene Therapy for STZ-Induced Diabetes.
Erendor F; Eksi YE; Sahin EO; Balci MK; Griffith TS; Sanlioglu S
Mol Ther; 2021 Jan; 29(1):149-161. PubMed ID: 33130311
[TBL] [Abstract][Full Text] [Related]
18. Construction of human insulin gene expression recombinant and its effect on blood glucose of diabetic rats.
Wang H; Xiao X; Fang F; Sun Q
Chin Med J (Engl); 1998 Oct; 111(10):899-902. PubMed ID: 11189235
[TBL] [Abstract][Full Text] [Related]
19. Glucose-regulated glucose uptake by transplanted muscle cells expressing glucokinase counteracts diabetic hyperglycemia.
Otaegui PJ; Ontiveros M; Ferre T; Riu E; Jiménez R; Bosch F
Hum Gene Ther; 2002 Dec; 13(18):2125-33. PubMed ID: 12542844
[TBL] [Abstract][Full Text] [Related]
20. Long-term glycemic control with hepatic insulin gene therapy in streptozotocin-diabetic mice.
Thulé PM; Campbell AG; Jia D; Lin Y; You S; Paveglio S; Olson DE; Kozlowski M
J Gene Med; 2015; 17(8-9):141-52. PubMed ID: 26190010
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
